Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform
Amount Raised
$95 Million
Round Type
Series C
BostonBiotechnologyDescription
Monte Rosa Therapeutics, a biotechnology company focused on discovering and developing precision medicines that degrade disease-causing proteins, announced today the closing of a $95 million Series C financing. The proceeds will be used to advance its lead development candidate into the clinic, accelerate pipeline growth and bolster its platform capabilities to rationally design and develop small molecule degraders (also known as molecular glues) that hijack the body’s innate ability to degrade proteins. Through this approach, Monte Rosa aims to eradicate undruggable proteins that cause or drive the progression of genomically-defined diseases intractable to standard care, including cancer.
Quick answer
Monte Rosa Therapeutics, Inc. raised $95 Million in a Series C round, dated March 12, 2021. Monte Rosa Therapeutics, Inc. is based in Boston, Massachusetts, United States.
- How much did Monte Rosa Therapeutics, Inc. raise?
- Monte Rosa Therapeutics, Inc. raised $95 Million in a Series C round on March 12, 2021.
- What does Monte Rosa Therapeutics, Inc. do?
- Monte Rosa Therapeutics is a biotechnology company developing molecular glues to degrade disease-causing proteins.
- Where is Monte Rosa Therapeutics, Inc. based and how big is it?
- Monte Rosa Therapeutics, Inc. is based in Boston, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Monte Rosa Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Celerpurus Inc raised $375K (Seed) on April 26, 2021.
- GPB Scientific, LLC raised $17M on April 23, 2021.
- BioCircuit Technologies raised $3.1M (Seed) on April 23, 2021.
- BioCircuit Technologies raised $1.5M (Seed) on April 23, 2021.
- Promedix, Inc. raised $250K on April 23, 2021.
- MED-X raised $225K on April 23, 2021.
Who to call at Monte Rosa Therapeutics, Inc., and when
A new round usually means Monte Rosa Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Monte Rosa Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Monte Rosa Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Monte Rosa Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Monte Rosa Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Monte Rosa Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.